US 12,234,234 B2
Method for synthesizing 1,7-naphthyridine derivatives
Wei Qian, Zhejiang (CN); Yuhua Shi, Shanghai (CN); Xing Huang, Zhejiang (CN); Changming Dong, Guizhou (CN); Junkui Dang, Gansu (CN); Zhipeng Wang, Hainan (CN); Yu Feng, Sichuan (CN); Hong Xu, Zhejiang (CN); Zongxi Huang, Anhui (CN); Ye Chen, Zhejiang (CN); Huafei Shen, Zhejiang (CN); and Jun Zhang, Anhui (CN)
Assigned to ChengDa Pharmaceuticals Co., Ltd., Zhejiang (CN)
Appl. No. 17/610,106
Filed by ChengDa PharmaCeuticals Co., Ltd., Zhejiang (CN)
PCT Filed Nov. 17, 2020, PCT No. PCT/CN2020/129254
§ 371(c)(1), (2) Date Nov. 9, 2021,
PCT Pub. No. WO2021/120953, PCT Pub. Date Jun. 24, 2021.
Claims priority of application No. 201911296069.2 (CN), filed on Dec. 16, 2019.
Prior Publication US 2022/0235044 A1, Jul. 28, 2022
Int. Cl. C07D 471/04 (2006.01)
CPC C07D 471/04 (2013.01) 13 Claims
 
1. A method for synthesizing 1,7-naphthyridine derivatives, comprising the following steps:
(1) dissolving Compound I, a protecting group reagent and an acid-binding agent in a solvent to make compound II at a reaction temperature of 20-150° C.;
wherein the molar ratio of said Compound I, said protecting group reagent and said acid-binding agent is 1.0:1.0˜10.0:0˜15.0,
wherein the compound I is a starting material and is 2-chloro-3-amino-pyridine;
said protecting group reagent is any one or more of di-tert-butyl dicarbonate, diisobnate, di-n-butyl dicarbonate, dibenzyl dicarbonate, diethyl dicarbonate, dimethyl dicarboutyl dicarbonate, di-n-propyl dicarbonate, diisopropyl dicarbonate, tert-butyl chloroformate, isobutyl chloroformate, n-butyl chloroformate, benzyl chloroformate, methyl chloroformate, ethyl chloroformate, n-propyl chloroformate and isopropyl chloroformate,
the corresponding protective group R1 in said compound II is any one or more of tert-butoxycarbonyl, isobutoxycarbonyl, n-butoxycarbonyl, benzyloxycarbonyl, methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl and isopropoxycarbonyl,
said acid-binding agent is any one or more of sodium hydroxide, potassium hydroxide, potassium carbonate, sodium carbonate, triethylamine and N-methylmorpholine;

OG Complex Work Unit Chemistry
(2) said Compound II is reacted with an aldehydation reagent under alkaline conditions to make Compound III,
wherein said aldehydation reagent is added dropwise, the temperature is ˜100˜10° C., the molar ratio of said Compound II, said alkali, said tetramethylethylene diamine and said aldehydation reagent is 1.0:1.0˜5.0:1.0˜5.0:1.0˜5.0,
said alkali is any one or more of n-butyl lithium, tert-butyl lithium, lithium diisopropylamide, and lithium hexamethyldisilazide,
said solvent is any one or more of tetrahydrofuran, methyltetrahydrofuran, dioxane, and methyl tert-butyl ether,
said aldehydation reagent is any one or more of dimethylformamide, diethylformamide, and N-formylmorpholine;
(3) said Compound III is cyclized with acrylate compounds make Compound IV with a Lewis acid,
wherein said Compound III, said Lewis acid and said acrylate compounds are dissolved in a solvent, and the temperature is 10˜120° C.,
said solvent is any one or more of ethyl acetate, isopropyl acetate, acetonitrile, tetrahydrofuran, methyltetrahydrofuran, dioxane and methyl tert-butyl ether,
said Lewis acid is any one or more of sodium tetrafluoroborate, lithium tetrafluoroborate, calcium tetrafluoroborate and potassium tetrafluoroborate,
said acrylate compounds are N,N-dimethylamino ethyl acrylate, N,N-dimethylamino acrylate, N,N-dimethylamino propyl acrylate and N,N-dimethylamino butyl acrylate,
the molar ratio of said Compound III, said Lewis acid and said acrylate compounds is 1.0:0.5˜10:1.0˜5.0,
R2 in said Compound IV is any one of a hydrogen atom, a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group and a tert-butyl group.